A first? COVID antibody therapy with full-year protection is up for FDA authorization: AZD7442, is designed to be used as a preventive measure to boost immunity for up to one year after a single, intramuscular injection

A first? COVID antibody therapy with full-year protection is up for FDA authorization: AZD7442, is designed to be used as a preventive measure to boost immunity for up to one year after a single, intramuscular injection
A first? COVID antibody therapy with full-year protection is up for FDA authorization: AZD7442, is designed to be used as a preventive measure to boost immunity for up to one year after a single, intramuscular injection submitted by /u/shallah
[link] [comments]
https://ift.tt/3mF1VdA October 09, 2021 at 10:13AM https://ift.tt/1R552o9

No comments:

Post a Comment